<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Leonardo</forename><surname>Tondo</surname></persName>
							<email>ltondo@aol.com</email>
							<affiliation key="aff0">
								<orgName type="institution">The International Consortium for Mood &amp; Psychotic Disorders Research</orgName>
								<address>
									<addrLine>MRC 306</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">McLean Hospital</orgName>
								<address>
									<addrLine>115 Mill Street</addrLine>
									<postCode>02478-9106</postCode>
									<settlement>Belmont</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><surname>Abramowicz</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Martin</forename><surname>Alda</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Bauer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Alberto</forename><surname>Bocchetta</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Lorenza</forename><surname>Bolzani</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Cynthia</forename><forename type="middle">V</forename><surname>Calkin</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Caterina</forename><surname>Chillotti</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Diego</forename><surname>Hidalgo-Mazzei</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mirko</forename><surname>Manchia</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bruno</forename><surname>Müller-Oerlinghausen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Murru</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Giulio</forename><surname>Perugi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marco</forename><surname>Pinna</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Giuseppe</forename><surname>Quaranta</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Daniela</forename><surname>Reginaldi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><surname>Reif</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Philipp</forename><surname>Ritter</surname><genName>Jr</genName></persName>
						</author>
						<author>
							<persName><forename type="first">Janusz</forename><forename type="middle">K</forename><surname>Rybakowski</surname></persName>
						</author>
						<author>
							<persName><forename type="first">David</forename><surname>Saiger</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Gabriele</forename><surname>Sani</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Selle</forename><surname>Valerio</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Stamm</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Gustavo</forename><forename type="middle">H</forename><surname>Vázquez</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">The International Consortium for Mood &amp; Psychotic Disorders Research</orgName>
								<address>
									<addrLine>MRC 306</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">McLean Hospital</orgName>
								<address>
									<addrLine>115 Mill Street</addrLine>
									<postCode>02478-9106</postCode>
									<settlement>Belmont</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Julia</forename><surname>Veeh</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Eduard</forename><surname>Vieta</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Ross</forename><forename type="middle">J</forename><surname>Baldessarini</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution">The International Consortium for Mood &amp; Psychotic Disorders Research</orgName>
								<address>
									<addrLine>MRC 306</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">McLean Hospital</orgName>
								<address>
									<addrLine>115 Mill Street</addrLine>
									<postCode>02478-9106</postCode>
									<settlement>Belmont</settlement>
									<region>MA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">30CE4194448FEA83D7250A9CA5F48C24</idno>
					<idno type="DOI">10.1186/s40345-017-0096-2</idno>
					<note type="submission">Received: 9 December 2016 Accepted: 18 April 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:50+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Blood urea nitrogen</term>
					<term>Body-mass index</term>
					<term>Creatinine</term>
					<term>eGFR</term>
					<term>Glomerular filtration rate</term>
					<term>Glucose</term>
					<term>Lithium</term>
					<term>Staging of renal function</term>
					<term>White blood cell count</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Concerns about potential adverse effects of long-term exposure to lithium as a mood-stabilizing treatment notably include altered renal function.</s><s>However, the incidence of severe renal dysfunction; rate of decline over time; effects of lithium dose, serum concentration, and duration of treatment; relative effects of lithium exposure vs. aging; and contributions of sex and other factors all remain unclear.</s></p><p><s>Methods: Accordingly, we acquired data from 12 collaborating international sites and 312 bipolar disorder patients (6142 person-years, 2669 assays) treated with lithium carbonate for 8-48 (mean 18) years and aged 20-89 (mean 56) years.</s><s>We evaluated changes of estimated glomerular filtration rate (eGFR) as well as serum creatinine, urea-nitrogen, and glucose concentrations, white blood cell count, and body-mass index, and tested associations of eGFR with selected factors, using standard bivariate contrasts and regression modeling.</s></p><p><s>Results: Overall, 29.5% of subjects experienced at least one low value of eGFR (&lt;60 mL/min/1.73</s><s>m 2 ), most after ≥15 years of treatment and age &gt; 55; risk of ≥2 low values was 18.1%; none experienced end-stage renal failure.</s><s>eGFR declined by 0.71%/year of age and 0.92%/year of treatment, both by 19% more among women than men.</s><s>Mean serum creatinine increased from 0.87 to 1.17 mg/dL, BUN from 23.7 to 33.1 mg/dL, glucose from 88 to 122 mg/dL, and BMI from 25.9 to 26.6 kg/m 2 .</s><s>By multivariate regression, risk factors for declining eGFR ranked: longer lithium treatment, lower lithium dose, higher serum lithium concentration, older age, and medical comorbidity.</s><s>Later low eGFR was also predicted by lower initial eGFR, and starting lithium at age ≥ 40 years.</s></p><p><s>Limitations: Control data for age-matched subjects not exposed to lithium were lacking.</s></p><p><s>Conclusions: Long-term lithium treatment was associated with gradual decline of renal functioning (eGFR) by about 30% more than that was associated with aging alone.</s><s>Risk of subnormal eGFR was from 18.1% (≥2 low values) to 29.5% (≥1 low value), requiring about 30 years of exposure.</s><s>Additional risk factors for low eGFR were higher serum lithium level, longer lithium treatment, lower initial eGFR, and medical comorbidity, as well as older age.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p><s>Decades of widespread international clinical use of lithium salts with controlled dosing, as well as extensive therapeutic research, support the value of lithium as a cornerstone of long-term, prophylactic treatment of patients diagnosed with bipolar disorder <ref type="bibr" target="#b12">(Bauer et al. 2006;</ref><ref type="bibr" target="#b9">Baldessarini 2013;</ref><ref type="bibr" target="#b51">Severus et al. 2014;</ref><ref type="bibr" target="#b11">Bauer and Gitlin 2016)</ref>.</s><s>Nevertheless, an adverse effect of major concern associated with long-term lithium treatment is the risk of developing chronic kidney disease (CKD).</s><s>This outcome usually is defined as a decrease of glomerular filtration rate (GFR) to &lt;60 mL/min per 1.73 m 2 observed at least twice in not less than 3 months <ref type="bibr" target="#b8">(Azab et al. 2015)</ref>.</s><s>Severe loss of renal function and end-stage renal disease (ESRD) are uncommon with lithium treatment, with a prevalence of approximately 1.5%, but 7-folds higher than the general population <ref type="bibr" target="#b1">(Aiff et al. 2015)</ref>.</s><s>Risk of renal dysfunction is believed to be associated with longer exposure to lithium as well as with advancing age with or without lithium, and appears to have changed little over the recent decades <ref type="bibr" target="#b1">(Aiff et al. 2015;</ref><ref type="bibr">Jonczyk-Potoczna et al. 2016)</ref>.</s><s>Pathological renal changes associated with long exposure to lithium in clinical doses have included the presence of macrocysts, microcysts, glomerulosclerosis, proximal tubular atrophy, and chronic interstitial fibrosis <ref type="bibr" target="#b2">(Albrecht et al. 1980;</ref><ref type="bibr" target="#b42">Oliveira et al. 2010;</ref><ref type="bibr" target="#b3">Alsady et al. 2016;</ref><ref type="bibr">Jonczyk-Potoczna et al. 2016)</ref>.</s><s>Molecular mechanisms associated with such dysfunction appear to be multiple and complex.</s><s>Based mainly on preclinical models, they include alterations in calcium signaling, inositol monophosphate and phosphodiesterase activities, prostaglandins, sodium-solute transport, G-protein-coupled receptors, nitric oxide, vasopressin aquaporin, and inflammation pathways <ref type="bibr" target="#b46">(Rej et al. 2016</ref>).</s><s>However, it is unclear why only some patients develop nephropathy in association with lithium treatment, regardless of age or lithium exposure.</s></p><p><s>At least 20 findings related to renal dysfunction have emerged from studies of patients treated long term with lithium <ref type="bibr" target="#b8">(Azab et al. 2015)</ref>.</s><s>They include (Table <ref type="table">1</ref>) (a) significant increase of serum creatinine concentration, not associated with age, in 99 lithium-treated patients followed for up to 10 years <ref type="bibr" target="#b26">(Depaulo et al. 1981)</ref>; (b) no difference in eGFR among 30 patients aged 55, treated with lithium for 6.2 years and 30 others not exposed to lithium <ref type="bibr" target="#b29">(Hullin et al. 1979</ref>); (c) no difference in eGFR among 32 patients aged 49 years, treated with lithium for 5.7 years and 32 matched controls <ref type="bibr" target="#b13">(Bendz 1985)</ref>; (d) more</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1 Reports on renal effects of lithium treatment</head><p><s>Abnormal renal functioning was associated with longer exposure to lithium in these studies (15.3 ± 9.54 vs. 5.00 ± 0.91 years, respectively [t = 2.37, p = 0.035])</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report</head><p><s>Subjects (n) Age (years) Lithium exposure (years) Main findings</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Li</head><p><s>No Li <ref type="bibr" target="#b29">Hullin et al. (1979)</ref>  prevalent low eGFR in 13 patients (mean age, 59 years) treated with lithium for 18 years (5/13) than that in 13 matched controls never exposed to lithium (0/13; χ 2 = 6.19, p = 0.01) <ref type="bibr" target="#b15">(Bendz et al. 1996)</ref>; (e) no difference in eGFR in 107 patients aged 39 treated with lithium for 4.5 years (eGFR = 86.5 ]) compared with 29 matched controls <ref type="bibr">(83.9 [76.1-91.7</ref>]</s><s>units) <ref type="bibr" target="#b24">(Coşkunol et al. 1997)</ref>  <ref type="bibr" target="#b33">(Kessing et al. 2015)</ref>.</s><s>To summarize, all these studies point out that lower eGFR is associated with older age and longer exposure to lithium (Table <ref type="table">1</ref>).</s></p><p><s>In addition to changes in renal functioning, the presence of macrocysts or microcysts as possible precursors of loss of kidney function has been reported in several renal-imaging studies following long-term lithium treatment <ref type="bibr" target="#b57">(Tuazon et al. 2008;</ref><ref type="bibr" target="#b54">Slaughter et al. 2010;</ref><ref type="bibr" target="#b27">Farshchian et al. 2013;</ref><ref type="bibr" target="#b32">Karaosmanoglu et al. 2013;</ref><ref type="bibr">Jonczyk-Potoczna et al. 2016)</ref>.</s><s>Also, an increase of renal neoplasia during long-term treatment with lithium has been suggested <ref type="bibr" target="#b61">(Zaidan et al. 2014)</ref>, but not supported by other observations <ref type="bibr" target="#b10">(Baldessarini and Tondo 2014;</ref><ref type="bibr" target="#b37">Licht et al. 2014;</ref><ref type="bibr" target="#b44">Pottegård et al. 2016)</ref>.</s></p><p><s>To extend the preceding findings, we evaluated effects of lithium on GFR and other metabolic parameters in a composite sample of 312 bipolar disorder patients followed for 8-48 years in 12 international specialized mood-disorder clinics with extensive experience in the clinical use of lithium.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>This international collaborative study involved data provided by 12 sites in Argentina, Canada, Germany, Italy, Poland, Spain, and Switzerland (Table <ref type="table" target="#tab_2">2</ref>).</s><s>Subjects were adults meeting DSM-IV diagnostic criteria for bipolar I or II disorder.</s><s>Participation was based on meeting local institutional requirements for the ethical conduct of research.</s><s>Measurements considered included age; sex; years of exposure to lithium treatment; mean daily dose of lithium carbonate and mean daily trough serum concentration of lithium; body-mass index (BMI), white blood cell counts (WBC), and assays of serum concentrations of glucose, blood urea nitrogen (BUN), and creatinine, with estimated GFR (eGFR, in units of mL/ min/1.73</s><s>m 2 ) computed according to the chronic kidney disease (CKD)-epidemiology collaboration (CKD-EPI) formulas for Caucasian (as all study subjects were) women and men <ref type="bibr" target="#b36">(Levey et al. 2009)</ref>:</s></p><p><s>Metabolic measures at baseline were compared over times of exposure to lithium treatment, ranging from 8 to 48 years, using ANOVA methods (t-scores).</s><s>Additional analyses focused on the prevalence of renal dysfunction based on low eGFR (&lt;60 mL/min/1.73</s><s>m 2 ), and considered standard functional staging, as: We addressed the prevalence of low values of eGFR across study sites, and changes with time and in association with selected measures, including ages (at onset, at lithium start and at the last follow up visit), sex, co-occurring medical illnesses, and exposure to lithium (by daily dose, mean serum concentration, and time) as well as to other psychotropic drugs (anticonvulsants, antidepressants, antipsychotics).</s><s>Associations of potential risk factors were tested by comparing subjects meeting the criterion of at least one low females : 141 × ([creatinine]/0.7)</s><s>−0.329 × ([creatinine]/0.7)</s><s>−1.209 × 0.993 age × 1.018; males : 141 × ([creatinine]/0.9)</s><s>−0.411 × ([creatinine]/0.9)</s><s>−1.209 × 0.993 age × 1.018.</s></p><p><s>value of eGFR (&lt;60 units) or not, in bivariate comparisons using ANOVA methods (t-scores) for continuous measures and contingency tables (χ 2 ) for categorical measures, followed by multivariable logistic regression modeling.</s><s>In order to differentiate effects on eGFR of age and lithium exposure, we also sampled subjects matched for long-term lithium exposure (20-25 years), but starting treatment at ages &lt;40 vs. ≥40 years.</s><s>Data are shown as mean ± standard deviation (SD) or with 95% confidence interval (CI), unless stated otherwise.</s><s>Analyses employed commercial software: Statview.5 (SAS Institute, Cary, NC, USA; for spreadsheets), and Stata.12</s><s>(StataCorp, College Station, TX, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subject characteristics</head><p><s>The pooled study sample consisted of 312 adult, bipolar disorder subjects, treated with lithium carbonate for 8-48 (mean 17.9 ± 8.62) years (with or without other treatments), representing a total exposure of 6142 person-years.</s><s>Selected characteristics of subjects from each site (subject count, age at entry to study site, age at last contact, and years treated with lithium) are summarized in Table <ref type="table" target="#tab_2">2</ref>.</s><s>The proportion of women/men was 57.7/42.3%;</s><s>age at study site intake averaged 37.9 ± 12.9 (range 11-76) years, and last age averaged 55.8 ± 14.2 (range 20-89) years.</s><s>Diagnoses were 78.2% bipolar I and 21.8% bipolar II, with an average age at illness-onset of 28.5 ± 11.1 years.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Metabolic parameters at baseline and during lithium treatment</head><p><s>Summary data for average measures and their status across years of treatment with lithium are based on 2669 assays (Table <ref type="table" target="#tab_4">3</ref>).</s><s>They include: lithium carbonate dose The dose of lithium carbonate declined significantly over the years (0.78%/year) whereas serum lithium concentrations remained stable over time, reflecting dosing adjustments as lithium clearance decreased with advancing age (Table <ref type="table" target="#tab_4">3</ref>).</s><s>BMI increased slightly, from 25.9 initially to a final mean value of 26.6 kg/m 2 , at a rate of 0.16%/year, and did not differ significantly between those given psychotropic drugs other than lithium or not (27.0 ± 5.36 vs. 26.3</s><s>± 3.72 kg/m 2 ; t = 1.36, p = 0.18).</s><s>Serum glucose concentration also rose significantly over years of treatment and with advancing age, at 0.79%/year.</s><s>BUN increased appreciably (from 23.7 to 33.1 mg/dL), at a rate of 1.4%/year, and creatinine rose at about half the rate of BUN, from 0.87 to 1.17 mg/dL, at 0.72%/year.</s></p><p><s>The metabolic measure of particular interest, eGFR, declined from a mean at intake of 94.2, to a final average of 62.2 mL/min/1.73</s><s>m 2 , at an average rate of decline of 0.915%/year (Table <ref type="table" target="#tab_4">3</ref>).</s><s>Times to first-observed significant increases in various measures vs. baseline included: BMI, just after the first year; glucose, from years 6-10; creatinine, years 16-20; and BUN, years 21-30.</s><s>Decline of eGFR was noted starting from years 6-10, with a projected decline to the lower limit of normal (60 units) after 30 or more years of exposure to lithium (Table <ref type="table" target="#tab_4">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Staging of renal deficiency</head><p><s>We considered changes in the prevalence of stages of renal function based on standard values (American National Kidney Foundation, NKF 2002, 2014) of eGFR, vs. years of lithium treatment (Fig. <ref type="figure" target="#fig_1">1</ref>).</s><s>The prevalence of normal or Stage I eGFR (≥90 mL/min/1.73</s><s>m 2 ) declined over years of lithium exposure (and advancing age), from 48.3% at intake to 9.80% after 31-48 years of exposure, whereas Stage 2 (60-89 units) declined slightly (from 50.8 to 44.1% of subjects), and the prevalence of abnormal eGFR Stages 3 and 4 eGFR (15-59 units) increased from 0.85 to 46.1%.</s><s>No subject reached end-stage renal failure (Stage 5).</s><s>The relative risk of each stage by sex (women/men) was: Stage 1, 0.72 (more in men); Stage 2, 1.11; Stage 3, 1.68; and Stage 4, 9.29 (all three more in women); these sex-differences were highly significant (overall χ 2 [df = 3] = 51.3,</s><s>p &lt; 0.0001).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Comparison of subjects with low vs. normal eGFR</head><p><s>A total of 92 (29.5%) of the 312 subjects had at least one estimate of eGFR below the lower limit of normal (&lt;60 mL/min/1.73</s><s>m 2 ).</s><s>Based on the widely accepted criterion of ≥2 low values <ref type="bibr" target="#b8">(Azab et al. 2015)</ref>, the risk of eGFR &lt; 60 units was 18.1% ].</s><s>Characteristics of subjects with vs. without low eGFR values were compared in initial bivariate comparisons (Tables <ref type="table" target="#tab_9">4, 5</ref>).</s><s>Subjects with significantly lower eGFR were (a) more often women than men; (b) older at illness-onset, at starting lithium, and at final observation; (c) significantly less likely to be given co-treatments with anticonvulsants or antipsychotics; and (d) having significantly lower initial values of eGFR ( Of note, antipsychotic drugs (59.2% of all subjects) were given with lithium more than either anticonvulsants (38.6%) or antidepressants (33.1%).</s><s>Based on multiple variable logistic regression modeling, adjusted for age and sex (not shown), mood-altering anticonvulsants were associated with shorter exposure to lithium and lower serum concentrations.</s><s>Use of antipsychotics was significantly greater among subjects diagnosed with bipolar I than II disorder, as well as shorter exposure to lithium   but at higher doses and serum concentrations.</s><s>Antidepressants were given more often to bipolar II than bipolar I disorder subjects.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Declining eGFR with age and exposure to lithium</head><p><s>As expected, advancing age and years of lithium treatment were associated with low values for eGFR (&lt;60 mL/min/1.73</s><s>m 2 ), with corresponding increases in rates of elevated serum creatinine concentration (defined as &gt;1.2 mg/dL, based on the lower standard value for women rather than that of 1.5 mg/dL for men) (Fig. <ref type="figure" target="#fig_2">2</ref>; Table <ref type="table" target="#tab_4">3</ref>).</s><s>The rate of decline (slope function as %/year) averaged 0.710%/year of age, with a nonsignificantly steeper decline among women than men (0.756 vs. 0.631%/year), and 0.915%/year of lithium exposure, with a significantly greater (non-overlapping CIs) rate of decline among women than men (0.934 vs. 0.785%/ year of lithium; Table <ref type="table" target="#tab_11">6</ref>).</s><s>The overall observed rate of decline of eGFR was 28.9% greater for years of lithium treatment than for years of age (0.915 vs. 0.710%/year; Table <ref type="table" target="#tab_11">6</ref>).</s></p><p><s>For comparison with subjects not exposed to lithium, we obtained data from a study by <ref type="bibr" target="#b47">Rule et al. (2004)</ref> who measured the effect of age in 365 healthy subjects on eGFR estimated as in the present study.</s><s>These data indicate a nonsignificantly lower rate of decline with age without than with lithium treatment (0.637 vs. 0.710%/ year), as well as a slightly larger decreases among women than men (Table <ref type="table" target="#tab_11">6</ref>).</s><s>In addition, the rate of decline of eGFR was significantly greater with years of exposure  to lithium (0.915%/year) than with age in subjects not exposed to lithium (0.637%/year; Table <ref type="table" target="#tab_11">6</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Renal effects of age at starting lithium treatment</head><p><s>Given the uncertain relative contributions of aging and exposure to lithium on declining eGFR, we considered a restricted sample of 610 assays, matched for longterm treatment with lithium for 20-25 years (mean for both = 22 years), but starting treatment at ages &lt;40 vs. ≥40 years (Table <ref type="table" target="#tab_12">7</ref>).</s><s>Mean eGFR was highly significantly lower among participants starting lithium at age ≥ 40 years.</s><s>Moreover, risk of low values of eGFR was nearly twice as high (1.94-times)</s><s>among the older subjects, despite similar exposure to lithium.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Multivariable regression modeling</head><p><s>Finally, we carried out multivariable logistic regression modeling of factors associated with low eGFR (&lt;60 mL/ min/1.73</s><s>m 2 ).</s><s>Factors remaining independently and significantly associated ranked: (a) longer treatment with lithium, (b) lower mean daily dose of lithium carbonate, (c) higher mean serum lithium concentration, (d) older age at the time of assays, (e) co-occurring medical illness (Table <ref type="table" target="#tab_13">8</ref>).</s><s>Not significantly associated with low eGFR in such modeling were sex, BMI, and co-treatment with an anticonvulsant, antipsychotic, or antidepressant drugs.</s><s>Of note, serum concentration was associated with low eGFR only when adjusted for age, dose, and duration of exposure (Table <ref type="table" target="#tab_13">8</ref>), but not without such adjustment (Tables <ref type="table" target="#tab_9">4, 5</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Among 312 adult bipolar disorder patients, treated for 8-48 years with lithium carbonate (6142 person-years of exposure), from 12 international collaborating centers we found an incidence of low eGFR (&lt;60 units) of 18.1% of subjects for ≥2 low values.</s><s>The risk was 29.5% using a broad criterion of one low value, for which the overall female/male risk ratio was 1.76.</s><s>Stage 1 eGFR (values of ≥90 units) was 39% more prevalent among men than women, whereas Stages 2 (60-89; by 11%), 3 (30-59; 68%), and 4 (15-29 units, by 9.3-fold) were more frequent among women.</s><s>No subject reached end-stage renal dysfunction (ESRD), perhaps reflecting the source of study data from specialized mood-disorder clinics where close clinical follow-up would lead to suspension of treatment before reaching ESRD.</s><s>Close clinical monitoring probably is also reflected in the lack of decline in average serum concentrations of lithium over years of treatment, despite a significant decline in total daily dose, presumably adjusted to maintain stable blood levels.</s></p><p><s>A particularly important finding is that eGFR declined with longer exposure to lithium treatment, but also with corresponding increases in age (Fig. <ref type="figure" target="#fig_2">2</ref>; Table <ref type="table" target="#tab_11">6</ref>).</s><s>Both factors were sustained as significant and independent in multivariable modeling (Table <ref type="table" target="#tab_13">8</ref>).</s><s>Effects of aging on renal function are well established even among human subjects without known disease or toxic factors <ref type="bibr" target="#b47">(Rule et al. 2004;</ref><ref type="bibr" target="#b60">Weinstein and Anderson 2010</ref>).</s><s>Although we did not have a comparison sample of patients followed over time without lithium treatment, we could compare rates of decline of eGFR as a function of age and of time of exposure to lithium, and with reported rates of decline in healthy subjects <ref type="bibr" target="#b47">(Rule et al. 2004</ref>).</s><s>Without lithium treatment, the rate of decline in eGFR (%/year) vs. age in normal subjects averaged 0.637 [CI 0.497-0.777]</s><s><ref type="bibr" target="#b47">(Rule et al. 2004</ref>), compared to 0.710 [0.653-0.767]</s><s>for age in lithium-treated subjects, and to 0.915 [0.822-1.08]</s><s>for years of lithium treatment (Table <ref type="table" target="#tab_11">6</ref>).</s><s>These estimates are similar, with overlapping confidence intervals for the effect of aging, but a higher rate with lithium exposure.</s><s>Additional reported data indicate a rate of decline of eGFR in healthy subjects of 0.708 [0.644-0.772]</s><s>%/year (American National Kidney Foundation, NKF 2014)-a value even closer to that found in our study for age among lithium-treated subjects.</s><s>We also addressed the relative contributions to declining eGFR by considering a sample of subjects matched for long-term exposure to lithium (22 years), but starting the treatment at ages &lt;40 vs. ≥40 years (Table <ref type="table" target="#tab_12">7</ref>).</s><s>Mean eGFR was significantly higher among participants who started lithium at older ages, and the risk of low values of eGFR was nearly twice greater among the older subjects, despite similar exposure to lithium.</s><s>These findings indicate that effects of  The rate of decline of eGFR averaged 0.92% per year of lithium treatment, and was 19% higher among women than men.</s><s>The observed overall rate of decline is consistent with most <ref type="bibr" target="#b15">(Bendz et al. 1996</ref><ref type="bibr" target="#b14">(Bendz et al. , 2010;;</ref><ref type="bibr" target="#b16">Bocchetta et al. 2013</ref><ref type="bibr" target="#b17">Bocchetta et al. , 2015;;</ref><ref type="bibr" target="#b23">Close et al. 2014;</ref><ref type="bibr" target="#b1">Aiff et al. 2015;</ref><ref type="bibr" target="#b53">Shine et al. 2015;</ref><ref type="bibr" target="#b33">Kessing et al. 2015;</ref><ref type="bibr" target="#b28">Hayes et al. 2016)</ref>, but not all <ref type="bibr" target="#b22">(Clos et al. 2015)</ref> retrospective reports on the effects of lithium on kidney function.</s><s>In the study by <ref type="bibr" target="#b22">Clos et al. (2015)</ref>, however, patients were exposed to lithium for an average of 55 months, possibly too brief to support detection of effects on kidney function <ref type="bibr" target="#b25">(Davis et al. 2015;</ref><ref type="bibr" target="#b18">Bocchetta et al. 2016)</ref>.</s><s>Interestingly, however, a similar lack of effect of lithium on renal function was found in a 4-years prospective study in elderly patients with mild cognitive impairment <ref type="bibr" target="#b6">(Aprahamian et al. 2014</ref>).</s><s>In the present findings, average values of eGFR became significantly lower than baseline levels by 6-10 years of treatment, and a mean decline to the lower limit of normal (60 units) required ≥30 years of exposure to lithium (Table <ref type="table" target="#tab_4">3</ref>).</s><s>Other reports of long-term lithium treatment effects on renal function are consistent with this observation <ref type="bibr" target="#b14">(Bendz et al. 2010;</ref><ref type="bibr" target="#b17">Bocchetta et al. 2015;</ref><ref type="bibr" target="#b53">Shine et al. 2015)</ref>.</s><s>We also found that risk of later low values of eGFR were strongly predicted by lower initial values (Table <ref type="table" target="#tab_6">4</ref>).</s><s>Exposure to lithium treatment needed to be at least 6-10 years to be associated with significant decreases of eGFR (Table <ref type="table" target="#tab_4">3</ref>).</s></p><p><s>Our finding of greater risk of a decline in eGFR among women is also consistent with some recent reports <ref type="bibr" target="#b17">(Bocchetta et al. 2015;</ref><ref type="bibr" target="#b53">Shine et al. 2015)</ref> suggesting a higher vulnerability of women to developing lithium-related effects on kidney.</s><s>Of note, however, other studies have found greater risk of declining eGFR among men <ref type="bibr" target="#b48">(Rybakowski et al. 2012;</ref><ref type="bibr" target="#b16">Bocchetta et al. 2013)</ref> or no sex difference <ref type="bibr" target="#b1">(Aiff et al. 2015)</ref>.</s></p><p><s>Serum concentrations of urea (BUN) increased by 1.41%/year, glucose by 0.787%/year, and creatinine by 0.724%/year-all rising with longer exposure to lithium and correspondingly advancing age.</s><s>The observed increase in serum glucose levels contrasts with a study reporting a nonsignificant increase in glucose levels after four years of treatment with lithium in elderly patients <ref type="bibr" target="#b6">(Aprahamian et al. 2014)</ref>.</s><s>Interestingly, studies in animals evaluating the effects of lithium on glucose metabolism also may be discordant with our findings <ref type="bibr" target="#b52">(Shah and Pishdad 1980;</ref><ref type="bibr" target="#b56">Tabata et al. 1994)</ref>.</s><s>Indeed, whereas <ref type="bibr" target="#b52">Shah and Pishdad (1980)</ref> found that lithium induced the hyperglycemia in rats, <ref type="bibr" target="#b56">Tabata et al. (1994)</ref> found a markedly increased sensitivity of glucose transport to insulin after lithium treatment.</s></p><p><s>We also found that average BMI increased by 0.162%/ year of treatment with lithium, with a significant increase over baseline values by the end of the first year of exposure, but little more thereafter (Table <ref type="table" target="#tab_4">3</ref>).</s><s>This finding confirms that lithium may contribute to weight gain <ref type="bibr" target="#b38">(Mathew et al. 1989;</ref><ref type="bibr" target="#b7">Atmaca et al. 2002)</ref>, although the effect might reflect exposure to other weight-increasing agents including antipsychotic drugs <ref type="bibr" target="#b19">(Calkin et al. 2009</ref>).</s><s>However, the potential adverse risks associated with long-term treatment with lithium need to be balanced against major clinical benefits of treatment with lithium <ref type="bibr" target="#b39">(McKnight et al. 2012;</ref><ref type="bibr" target="#b50">Severus and Bauer 2013;</ref><ref type="bibr" target="#b33">Kessing et al. 2015)</ref>.</s></p><p><s>Several factors were associated with loss of eGFR during long-term treatment with lithium (Tables <ref type="table" target="#tab_13">4, 5, 6, 7  and 8</ref>).</s><s>Notably, declining eGFR was associated with serum lithium concentrations only when adjusted for age, dose of lithium, and duration of lithium exposure, whereas total daily doses of lithium carbonate were actually lower with low eGFR, in association with older age (Tables <ref type="table" target="#tab_13">4, 5, and 8</ref>).</s><s>These findings suggest that dose was adjusted to maintain therapeutic serum levels in the face of declining renal clearance of lithium and with age.</s><s>We also found that medical comorbidities (especially diabetes and hypertension) were associated with declining eGFR.</s><s>In contrast, use of adjunctive treatments, especially modern antipsychotic drugs and mood-altering anticonvulsants, were associated with less risk of low eGFR values (Tables <ref type="table" target="#tab_9">4, 5</ref>).</s><s>These associations are not readily explained.</s><s>Patients with low eGFR were older, had more general medical comorbidity, and were given fewer psychotropic drugs of all kinds as well as lower doses of lithium.</s><s>Of note, there is suggestive evidence that anticonvulsants and antipsychotics may themselves contribute to risk of renal damage <ref type="bibr" target="#b30">(Hwang et al. 2014;</ref><ref type="bibr" target="#b33">Kessing et al. 2015)</ref>.</s><s>Other findings implicate episodes of acute lithium intoxication (possibly an indication of more aggressive treatment) with declining renal function <ref type="bibr" target="#b45">(Rej et al. 2012</ref>).</s></p><p><s>There may be effects of once-daily vs. multiple daily dosing with lithium on renal function <ref type="bibr" target="#b20">(Carter et al. 2013;</ref><ref type="bibr" target="#b21">Castro et al. 2016)</ref>.</s><s>Some evidence suggests less renal toxicity with once-daily dosing, but the findings are inconsistent, and may be confounded by likely use of lower doses with once-daily regimens <ref type="bibr" target="#b49">(Schou et al. 1982;</ref><ref type="bibr" target="#b20">Carter et al. 2013)</ref>.</s><s>Moreover, the observed effects pertain mainly to small reductions in 24-h urine volume <ref type="bibr" target="#b35">(Kusalic and Engelsmann 1996)</ref>.</s><s>Once-daily dosing is perhaps best reserved for young, vigorous patients given moderate doses of lithium to limit the potentially toxic impact of high, daily peak serum concentrations.</s><s>Reducing lithium dose might be expected to limit toxic effects as was supported by present findings (Tables <ref type="table" target="#tab_9">4, 5</ref>, assuming that dose was not lowered because of declining renal function).</s><s>Lithium dose can be reduced by use of combinations with other agents with mood-stabilizing effects, including some anticonvulsants or antipsychotics.</s></p><p><s>Consideration of these factors during appropriately close, long-term clinical monitoring should help to limit risks of renal impairment with long-term lithium treatment <ref type="bibr" target="#b43">(Paul et al. 2010</ref>).</s><s>In addition, there may be benefits in monitoring serum concentrations of lithium levels relatively frequently, especially in elderly patients.</s><s>It has been suggested that lithium levels should be monitored every 3 months since even a single occurrence of a level higher than 1.0 mEq/L may result in a modest but significant decrease of the GFR lasting for at least 3 months <ref type="bibr" target="#b12">(Bauer et al. 2006;</ref><ref type="bibr" target="#b59">Van Beneden et al. 2011;</ref><ref type="bibr" target="#b34">Kirkham et al. 2014;</ref><ref type="bibr" target="#b25">Davis et al. 2015;</ref><ref type="bibr" target="#b53">Shine et al. 2015)</ref>.</s><s>In general, we would emphasize the importance of appropriate selection of patients for long-term lithium treatment, maintaining them on minimum effective doses and daily trough serum concentrations especially for older populations, and regular monitoring to assess adherence to prescribed treatment.</s><s>These principles of safe practice are important to emphasize, especially as many mood-disorder patients are followed by primary-care clinicians and are not followed in specialized programs directed by experts <ref type="bibr" target="#b41">(Müller-Oerlinghausen et al. 2012)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Limitations</head><p><s>The present findings should be interpreted in the context of some limitations.</s><s>First, the study is retrospective in nature.</s><s>However, clinical data were collected longitudinally in specialized mood-disorder clinics where patients are followed up systematically and at regular intervals, increasing the statistical accuracy of gathered information.</s><s>Second, the main measure of renal function in this study was estimated GFR based on serum concentrations of creatinine, and not on independently verified clearance of an exogenous test molecule.</s><s>The formulas employed may not adequately reflect the rate of glomerular filtration at very high concentrations of creatinine, such as &gt;1.75 mg/dL <ref type="bibr" target="#b36">(Levey et al. 2009;</ref><ref type="bibr" target="#b55">Stevens 2013)</ref>.</s><s>Nevertheless, eGFR is widely employed measure of renal function and is readily obtained for routine clinical use.</s><s>Finally, we lacked a comparison group without lithium treatment, leaving the important question of effects of aging vs. of lithium on eGFR unresolved.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>This multisite, international, long-term study found significant changes in renal function and other metabolic measures in association with very prolonged treatment with lithium carbonate given to prevent recurrences of bipolar disorder.</s><s>It adds to evidence that long-term lithium treatment is associated with a decline in renal function as expressed by significant decreases of eGFR over time.</s><s>We found moderate decreases in eGFR after prolonged exposure to lithium (at least 6-10 years) and advancing age, along with increases in serum creatinine and BUN concentrations, and small increases in glucose levels and BMI.</s><s>No cases of severe or end-stage renal failure were encountered, probably owing to close clinical monitoring and timely interventions in cases with declining renal function.</s><s>We found greater decreases in eGFR among women than men, and following lower initial values of eGFR, as well as when lithium treatment was started at older ages.</s><s>The study findings contribute to clarifying relationships between long-term lithium treatment and its metabolic safety profile.</s><s>Overall, this study and those summarized above (Table <ref type="table">1</ref>) indicate, with some notable inconsistencies, that there were major risks of declining eGFR with very prolonged treatment with lithium salts, but that effects of advancing age also are prominent and confound quantification of risk-by-time specific to lithium exposure.</s><s>Noteworthy risk factors for low eGFR included female sex, higher serum lithium level, longer lithium treatment, lower initial eGFR, and medical comorbidity, as well as older age.</s><s>A clinically favorable conclusion is that emerging decreases in renal function can be detected readily with regular metabolic monitoring, and probably modified by timely interventions that include an increasing number of apparently effective treatment options to lithium.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>Stage 1 normal functioning (GFR ≥ 90); Stage 2 mildly decreased functioning (GFR = 60-89); Stage 3 moderate dysfunction (GFR = 30-59); Stage 4 severe dysfunction (GFR = 15-29); and Stage 5 kidney failure (GFR &lt; 15 or needing dialysis) (American National Kidney Foundation, NKF 2002, 2014).</s><s>Low eGFR included Stages 3 and 4.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1</head><label>1</label><figDesc><div><p><s>Fig. 1 Proportion (%) of subjects with Stages 1, 2, or 3 and 4 of renal function vs. years of lithium exposure.</s><s>By linear regression, the prevalence of Stage 1 renal function (normal) declined highly significantly (slope [β]: −1.12 [CI −1.36 to −0.88]; t = 10.6, p &lt; 0.0001); Stage 2 (mild dysfunction) remained stable (β: -0.035 [CI −0.373 to 0.303], t = 0.23, p = 0.82); and Stages 3 + 4 increased highly significantly (β: +1.15 [CI 0.91-1.40],</s><s>t = 10.7,</s><s>p &lt; 0.0001)</s></p></div></figDesc><graphic coords="6,68.99,94.83,209.76,152.76" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 2</head><label>2</label><figDesc><div><p><s>Fig. 2 Values of eGFR (mL/min) [with 95% CI] among men and women: a vs. age; b vs. years of lithium treatment, pooled from 12 international sites, involving 2669 measurements among 312 bipolar disorder subjects treated with lithium for 8-44 years</s></p></div></figDesc><graphic coords="7,63.00,296.32,470.52,241.08" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 Subject age and lithium exposure across study sites</head><label>2</label><figDesc><div><p><s>Total exposure = 6142 person-years Across the 12 sites, among 312 subjects: a t = 1.55, p = 0.007; b t = 1.70, p = 0.001; c t = 1.13, p = 0.24</s></p></div></figDesc><table><row><cell>Study site</cell><cell>Subjects (n)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Intake age a Final age b Years on Li c</head><label></label><figDesc></figDesc><table><row><cell>Barcelona: University of Barcelona Berlin: Charité Medical Center Buenos Aires: Palermo University Cagliari: Lucio Bini Mood Disorder Center Cagliari: University of Cagliari Dresden: University of Dresden Halifax: Dalhousie University Lugano: Viarnetto Clinic Pisa: University of Pisa Poznan: University of Poznan Rome: Lucio Bini Mood Disorder Center Würzburg: University of Würzburg Total [95% CI] (833 ± 311 mg/day), mean daily trough serum concen-26 30 9 50 30 22 27 21 25 20 46 6 312 trations of lithium (0.656 ± 0.184 mEq/L), body-mass index (BMI, 27.0 ± 4.86 kg/m 2 ), serum glucose concen-tration (97.3 ± 28.4 mg/dL), blood urea nitrogen (BUN, 26.1 ± 12.9 mg/dL), serum creatinine concentration (0.92 ± 0.24 mg/dL), and estimated glomerular filtration rate (eGFR; 83.3 ± 21.8 mL/min/1.73 m 2 ). In addition, white blood cell count ([WBC] not shown) was initially 7.29 and finally 7.59 × 10 −3 /µL, without appreciable change over years of lithium treatment.</cell><cell>32.3 ± 8.06 39.5 ± 12.4 47.2 ± 12.0 38.1 ± 12.1 37.1 ± 11.2 33.5 ± 12.7 43.5 ± 13.7 33.8 ± 11.6 37.6 ± 13.1 43.1 ± 14.2 36.8 ± 15.6 45.0 ± 14.9 37.9 [37.5-39.3]</cell><cell>51.8 ± 11.4 56.6 ± 14.9 62.3 ± 13.4 54.6 ± 14.5 62.2 ± 13.1 53.8 ± 13.2 55.4 ± 13.7 52.0 ± 12.9 49.4 ± 13.8 66.2 ± 10.7 54.6 ± 15.9 61.8 ± 9.75 55.8 [54.2-57.4]</cell><cell>19.4 ± 7.41 17.2 ± 8.12 15.1 ± 5.93 17.5 ± 8.61 24.1 ± 8.86 20.3 ± 9.49 11.9 ± 3.97 17.9 [16.9-18.9] 6.80 ± 7.94 18.4 ± 9.47 23.1 ± 8.59 11.7 ± 6.29 18.2 ± 9.45</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3 Metabolic parameters in lithium-treated bipolar disorder patients</head><label>3</label><figDesc><div><p><s>Data are based on means of N measurements (of a total of 2669) for 312 subjects over stated exposures to lithium treatment Not shown are data for white blood cell counts (WBC), which did not change appreciably (initital: 7.29, final: 7.59 × 10 -3 per µL) BMI (body-mass index [kg/m 2 ]), BUN (blood urea nitrogen [mg/dL]), creatinine [mg/dL], eGFR (estimated glomerular filtration rate for creatinine [mL/min/1.73</s><s>m 2 ]), glucose (not necessarily fasting [mg/dL]), WBC (white blood cell count [thousands/µL]) a Values differ significantly from baseline measure, based on Tukey-Kramer post hoc tests comparing each exposure-interval to baseline values</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Exposure (years) N Lithium dose (mg/day) Serum [Li + ] (mEq/L) BMI (kg/m 2 ) Glucose (mg/ dL) BUN (mg/dL) Creatinine (mg/dL) eGFR (mL/ min/1.73 m 2 )</head><label></label><figDesc></figDesc><table><row><cell cols="2">Baseline 1 2-5 6-10 11-15 16-20 21-30 ≥31 Means [95% CI] 312 subjects 833 ± 311 312 797 ± 283 312 859 ± 282 1561 877 ± 296 a 1490 875 ± 310 a 1080 858 ± 320 739 815 ± 305 760 716 ± 289 a 201 647 ± 334 a [824-842]</cell><cell>0.594 ± 0.201 0.638 ± 0.171 0.658 ± 0.185 0.656 ± 0.177 0.672 ± 0.188 0.671 ± 0.191 0.651 ± 0.172 0.607 ± 0.168 0.656 ± 0.184 [0.650-0.662]</cell><cell>25.9 ± 4.81 27.9 ± 5.87 a 27.3 ± 5.10 a 27.5 ± 5.15 a 27.0 ± 4.57 27.6 ± 4.71 a 27.6 ± 4.30 a 26.6 ± 5.03 27.0 ± 4.86 [26.5-27.5]</cell><cell>88.1 ± 14.3 90.5 ± 16.3 90.9 ± 17.9 97.4 ± 28.6 a 95.3 ± 24.0 a 98.6 ± 28.4 a 103.8 ± 33.5 a 121.9 ± 54.9 a 97.3 ± 28.4 [94.1-100.5]</cell><cell>23.7 ± 11.4 22.1 ± 10.4 23.8 ± 10.8 24.5 ± 11.2 25.4 ± 11.7 26.9 ± 14.1 31.2 ± 15.7 a 33.1 ± 15.8 a 26.1 ± 12.9 [24.7-27.5]</cell><cell>0.87 ± 0.19 0.86 ± 0.17 0.87 ± 0.17 0.90 ± 0.19 0.91 ± 0.21 0.93 ± 0.24 a 0.98 ± 0.29 a 1.17 ± 0.48 a 0.92 ± 0.24 [0.89-0.95]</cell><cell>94.2 ± 23.3 94.8 ± 22.2 91.2 ± 21.1 86.1 ± 20.1 a 83.9 ± 20.2 a 78.8 ± 19.3 a 72.7 ± 20.1 a 62.2 ± 22.9 a 83.3 ± 21.8 [80.9-85.7]</cell></row><row><cell>Change (%/ year)</cell><cell>2669 assays -0.777 [-0.654 to -0.901]</cell><cell>-0.005 [-0.118 to -0.118]</cell><cell>+0.162 [0.011-0.311]</cell><cell>+0.787 [0.619-0.954]</cell><cell>+1.41 [1.10-1.72]</cell><cell>+0.724 [0.609-0.839]</cell><cell>-0.915 [-0.822 to -1.01]</cell></row><row><cell>p value</cell><cell cols="2">2669 assays &lt;0.0001 [12.4] 0.94 [0.077]</cell><cell>0.04 [2.11]</cell><cell cols="4">&lt;0.0001 [9.21] &lt;0.0001 [8.91] &lt;0.0001 [12.4] &lt;0.0001 [19.1]</cell></row><row><cell>[t-score]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>Table 4</head><label>4</label><figDesc></figDesc><table><row><cell>). In addition, measures</cell></row><row><cell>associated with low eGFR based on all assays, included</cell></row><row><cell>(e) older at the time of assays; (f ) more likely to have</cell></row><row><cell>medical comorbidities (mainly cardiovascular diseases,</cell></row><row><cell>diabetes, hypercholesterolemia, hypertension, hypertri-</cell></row><row><cell>glyceridemia, hypothyroidism, or respiratory diseases);</cell></row><row><cell>(g) longer exposure to lithium; (h) lower average doses</cell></row><row><cell>of lithium carbonate; (i) without differences in mean</cell></row><row><cell>serum lithium concentrations; (j) higher mean BUN; (k)</cell></row><row><cell>higher serum glucose concentration; and (l) higher BMI</cell></row><row><cell>(Table 5). Factors not associated with low eGFR included</cell></row><row><cell>(a) diagnosis; (b) educational level; (c) metabolic syn-</cell></row><row><cell>drome; (d) abuse of alcohol or drugs; (e) cigarette smok-</cell></row><row><cell>ing; (f ) lifetime suicidal behavior, and (g) serum TSH</cell></row><row><cell>levels.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>Table 4 Factors associated with vs. without low eGFR among 312 bipolar disorder subjects treated long-term with lithium</head><label>4</label><figDesc></figDesc><table><row><cell>Means are with 95% CI. Serum lithium concentration is in mEq/L; dose is of</cell></row><row><cell>lithium carbonate is total mg/day. Additional factors not associated with low</cell></row><row><cell>eGFR: (1) diagnosis (bipolar I vs. bipolar II), (2) education, (3) metabolic syndrome</cell></row><row><cell>(overall risk = 30.4%), (4) any substance abuse, (5) alcohol abuse, (6) smoking, (7) any suicidal act, (8) serum TSH. Medical illnesses include cardiovascular and</cell></row><row><cell>metabolic syndromes</cell></row><row><cell>a Low eGFR: subjects with at least one value &lt;60 mL/min/1.73 m 2 ; the observed</cell></row><row><cell>rate of such subjects was 92/312 (29.5%), but 312/2669 assays (11.3%)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>Factor Low eGFR a Normal eGFR p-value [χ 2 or t-score]</head><label></label><figDesc></figDesc><table><row><cell>Subjects</cell><cell>92</cell><cell>220</cell><cell>-</cell></row><row><cell>Sex (%)</cell><cell></cell><cell></cell><cell>0.003 [8.98]</cell></row><row><cell>Women</cell><cell>36.1</cell><cell>63.9</cell><cell></cell></row><row><cell>Men</cell><cell>20.5</cell><cell>79.5</cell><cell></cell></row><row><cell>Ages (years)</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Illness onset</cell><cell cols="3">31.8 [29.4-34.2] 27.1 [25.7-28.5] 0.0007 [3.41]</cell></row><row><cell>Started lithium</cell><cell cols="3">42.5 [39.8-45.2] 35.9 [34.2-37.6] &lt;0.0001 [4.19]</cell></row><row><cell>Final lithium</cell><cell cols="3">65.0 [62.4-67.6] 52.0 [50.3-53.7] &lt;0.0001 [8.09]</cell></row><row><cell>Co-treatments (%)</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Anticonvulsants 23.7</cell><cell>45.5</cell><cell>0.001 [10.4]</cell></row><row><cell>Antipsychotics</cell><cell>47.4</cell><cell>64.6</cell><cell>0.01 [6.40]</cell></row><row><cell cols="2">Antidepressants 25.0</cell><cell>36.1</cell><cell>0.07 [3.25]</cell></row><row><cell>Initial eGFR</cell><cell>77.2 ± 16.1</cell><cell>94.6 ± 21.9</cell><cell>&lt;0.0001 [6.74]</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_9"><head>Table 5 Measures associated with vs. without low eGFR among 2669 assays in 312 bipolar disorder subjects treated long-term with lithium</head><label>5</label><figDesc></figDesc><table /><note><p><s>Means are with 95% CI.Serum lithium concentration is in mEq/L; dose is of lithium carbonate is total mg/day.Additional factors not associated with low eGFR: (1) diagnosis (bipolar I vs. bipolar II), (2) education, (3) metabolic syndrome (overall risk = 30.4%),(4)any</s><s>substance abuse, (5) alcohol abuse, (6) smoking, (7) any suicidal act, (8) serum TSH.Medical illnesses include cardiovascular and metabolic syndromes a Low eGFR: subjects with at least one value &lt;60 mL/min/1.73m 2 ; the observed rate of such subjects was 92/312 (29.5%), but 312/2669 assays (11.3%) b Most frequent medical comorbidities are: cardiovascular diseases, diabetes, hypercholesterolemia, hypertension, hypertriglyceridemia, hypothyroidism, and respiratory diseasesMeasureLow</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_10"><head>eGFR a Normal eGFR p-value [χ 2 or t-score]</head><label></label><figDesc></figDesc><table><row><cell>Age at assay</cell><cell cols="3">62.7 [61.4-64.0] 48.0 [47.5-48.5] &lt;0.0001 [18.3]</cell></row><row><cell>Medical comor-</cell><cell>83.5</cell><cell>59.5</cell><cell>&lt;0.0001 [41.3]</cell></row><row><cell>bidity (%) b</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Lithium exposure</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Years treated</cell><cell cols="3">19.6 [18.5-20.7] 11.2 [10.9-11.5] &lt;0.0001 [16.3]</cell></row><row><cell>Mean dose</cell><cell>588 [554-622]</cell><cell>884 [871-896]</cell><cell>&lt;0.0001 [15.5]</cell></row><row><cell>Mean serum</cell><cell cols="3">0.65 [0.63-0.68] 0.66 [0.65-0.67] 0.32 [0.99]</cell></row><row><cell>[Li+]</cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">Physiological measures</cell><cell></cell><cell></cell></row><row><cell>BUN</cell><cell cols="3">36.7 [34.3-39.1] 24.6 [24.0-25.2] &lt;0.0001 [12.6]</cell></row></table><note><p><s>[Glucose] 108 [103-112] 95.8 [94.4-97.2]</s><s>&lt;0.0001 [5.88] BMI 28.5 [26.2-30.8]</s><s>26.4 [25.9-26.9]</s><s>0.03 [2.22]</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_11"><head>Table 6 Rate of decrease of eGFR with age and lithium exposure (%/year)</head><label>6</label><figDesc><div><p><s>Rule et al. (2004)bjects are from the present study.Data for healthy adults are adapted fromRule et al. (2004)for clearance of iothalamate.</s><s>Rates of GFR decrease as %/year are computed as [initial eGFR − observed eGFR]/[initial eGFR] × 100 with 95% confidence intervals and number (n) of subjects (eGFR is in units of mL/ min/1.73</s><s>m 2 )</s></p></div></figDesc><table><row><cell>Group</cell><cell>eGFR decrease, %/year [95% CI] (n)</cell><cell></cell><cell></cell></row><row><cell></cell><cell>Age: healthy adults</cell><cell>Age: lithium-treated</cell><cell>Years of lithium</cell></row><row><cell>All subjects</cell><cell>0.637 [0.497-0.777] (365)</cell><cell>0.710 [0.653-0.767] (312)</cell><cell>0.915 [0.822-1.08] (312)</cell></row><row><cell>Men</cell><cell>0.488 [0.361-0.616] (160)</cell><cell>0.631 [0.545-0.717] (132)</cell><cell>0.785 [0.546-0.717] (132)</cell></row><row><cell>Women</cell><cell>0.754 [0.580-0.928] (205)</cell><cell>0.756 [0.682-0.829] (180)</cell><cell>0.934 [0.815-1.05] (180)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_12"><head>Table 7 Patients started on lithium treatment below or above age 40 Measure Age &lt; 40 Age ≥ 40 p-value (t or χ 2 )</head><label>7</label><figDesc></figDesc><table><row><cell>Subjects (n)</cell><cell>426</cell><cell>184</cell><cell>-</cell></row><row><cell>Years of lithium Mean eGFR eGFR &lt; 60 units (%)</cell><cell>22.3 ± 1.69 77.6 ± 19.9 37.1</cell><cell>22.1 ± 1.63 68.3 ± 17.9 72.3</cell><cell>0.123 (0.35) &lt;0.0001 (4.02) &lt;0.0001 (63.8)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_13"><head>Table 8 Multivariate logistic regression model for factors associated with low eGFR (&lt;60 mL/min/1.73 m 2 )</head><label>8</label><figDesc></figDesc><table><row><cell>Factor</cell><cell cols="2">Odds ratio [95% CI] z-score p-value</cell></row><row><cell>Longer lithium treatment</cell><cell>1.07 [1.04-1.09] 5.92</cell><cell>&lt;0.0001</cell></row><row><cell>(years)</cell><cell></cell><cell></cell></row><row><cell>Lower mean lithium dose (mg/</cell><cell>1.003 [1.002-1.004] 5.42</cell><cell>&lt;0.0001</cell></row><row><cell>day)</cell><cell></cell><cell></cell></row><row><cell>Higher mean serum [Li + ]</cell><cell>4.47 [4.36-43.5] 4.47</cell><cell>&lt;0.0001</cell></row><row><cell>Older age at assay</cell><cell>1.04 [1.02-1.06] 4.32</cell><cell>&lt;0.0001</cell></row><row><cell>Co-occurring medical illness</cell><cell>2.11 [1.28-3.49] 2.91</cell><cell>0.004</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>The authors offer their thanks to Kathleen Cairns, Julie Garnham, Terry McCarvill, and</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Authors' contributions</head><p><s>All the authors contributed to this paper by providing data and discussing the design and results of the study, and preparation of this report.</s><s>All the authors read and approved the final manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author details</head><p><s>1 Department of Psychiatry, Harvard Medical School, Boston, MA, USA. 2 The International Consortium for Mood &amp; Psychotic Disorders Research, MRC  306, McLean Hospital, 115 Mill Street, Belmont, MA 02478-9106, USA. 3</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Availability of data and materials</head><p><s>Data were made available by all participants/authors of the study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Consent for publication</head><p><s>All patients signed an informed consent to publication of anonymous and aggregate data derived from their medical records.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics approval and consent to participate</head><p><s>The study has been approved by local Ethical Committee according to national laws which allow the anonymous and aggregate use of human data if not involved in any experimental designs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Publisher's Note</head><p><s>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">End-stage renal disease associated with prophylactic lithium treatment</title>
		<author>
			<persName><forename type="first">H</forename><surname>Aiff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">O</forename><surname>Attman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Aurell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bendz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schön</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Svedlund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Neuropsychopharmacol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="540" to="544" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Effects of 10 to 30 years of lithium treatment on kidney function</title>
		<author>
			<persName><forename type="first">H</forename><surname>Aiff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">O</forename><surname>Attman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Aurell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bendz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ramsauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schön</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Svedlund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="608" to="614" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Renal function and biopsy in patients on lithium therapy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Albrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kampf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Müller-Oerlinghausen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacopsychiatry Neuropsychopharmacol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="228" to="234" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Lithium in the kidney: friend and foe?</title>
		<author>
			<persName><forename type="first">M</forename><surname>Alsady</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Baumgarten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Deen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>De Groot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="1587" to="1595" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">American National Kidney Foundation. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification</title>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="S1" to="266" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title level="m" type="main">American National Kidney Foundation, NKF. Frequently asked questions about GFR estimates</title>
		<ptr target="www.kidney.org/sites/default/files/docs/12-10-4004_abe_figs_aboutgfrrev1b_singleb.pdf.Accessed" />
		<imprint>
			<date type="published" when="2014-09-10">2014. 10 Sept 2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Long-term, low-dose lithium treatment does not impair renal function in the elderly: 2-year randomized, placebo-controlled trial followed by single-blind extension</title>
		<author>
			<persName><forename type="first">I</forename><surname>Aprahamian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Talib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Diniz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Radanovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="e672" to="678" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Weight gain and serum leptin levels in patients on lithium treatment</title>
		<author>
			<persName><forename type="first">M</forename><surname>Atmaca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kuloglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tezcan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ustundag</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychobiology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="67" to="69" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Lithium nephrotoxicity</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Azab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shnaider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Osher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bersudsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Belmaker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Bipolar Disord</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">13</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Baldessarini</surname></persName>
		</author>
		<title level="m">Chemotherapy in Psychiatry</title>
				<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<publisher>Springer Press</publisher>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>2nd ed</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Are renal tumors associated with lithium treatment?</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Baldessarini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tondo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Bipolar Disord</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">6</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main">The essential guide to lithium treatment</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gitlin</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016">2016</date>
			<publisher>Springer Press</publisher>
			<pubPlace>Cham</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Grof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Müller-Oerlinghausen</surname></persName>
		</author>
		<title level="m">Lithium in neuropsychiatry: the comprehensive guide</title>
				<imprint>
			<publisher>Abingdon: Informa Press</publisher>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Kidney function in a selected lithium population. A prospective, controlled, lithium-withdrawal study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bendz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Psychiatr Scand</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="451" to="463" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Renal failure occurs in chronic lithium treatment but is uncommon</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bendz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schön</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">O</forename><surname>Attman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Aurell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="219" to="224" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithiumwithdrawal study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bendz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Sjödin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Aurell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nephrol Dial Transpl</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="457" to="460" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bocchetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ardau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Carta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ligas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sardu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Del</forename><surname>Zompo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Med</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">33</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Renal function during long-term lithium treatment: a cross-sectional and longitudinal study</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bocchetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ardau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fanni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sardu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Piras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Del</forename><surname>Zompo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">12</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Long-term lithium and estimated glomerular filtration rate</title>
		<author>
			<persName><forename type="first">A</forename><surname>Bocchetta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sardu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Piras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Psychiatry</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="105" to="106" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Can body mass index help predict outcome in patients with bipolar disorder?</title>
		<author>
			<persName><forename type="first">C</forename><surname>Calkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Van De Velde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Růzicková</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Slaney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Garnham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hajek</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bipolar Disord</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="650" to="656" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">An updated review of the optimal lithium dosage regimen for renal protection</title>
		<author>
			<persName><forename type="first">L</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zolezzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lewxzyk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="595" to="600" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Stratifying risk for renal insufficiency among lithium-treated patients: electronic health record study</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Roberson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Mccoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wiste</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cagan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Smoller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1138" to="1143" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: a population-based cohort study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Clos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rauchhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Severn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cochrane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Donnan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Psychiatry</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1075" to="1083" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Renal failure in lithium-treated bipolar disorder: a retrospective cohort study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Close</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Reilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Mason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kripalani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Main</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Hungin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e90169</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Renal side-effects of long-term lithium treatment</title>
		<author>
			<persName><forename type="first">H</forename><surname>Coşkunol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Vahip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Mees</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Başçi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Bayindir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Tuğlulaŕ</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Affect Disord</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="5" to="10" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Prevention of lithium-associated renal failure: recent evidence</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rosenbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Shahinian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Brosius</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Psychiatry</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1045" to="1047" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Renal glomerular function and long-term lithium therapy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Depaulo</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Correa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Sapir</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Psychiatry</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="324" to="327" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">MRI findings and renal function in patients on lithium therapy</title>
		<author>
			<persName><forename type="first">N</forename><surname>Farshchian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Farnia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Aghaiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Abdoli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Drug Saf</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="257" to="260" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a population-based cohort study</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Marston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Walters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Geddes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Osborn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">e100205</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Renal function after longterm treatment with lithium</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Hullin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Coley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Birch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Morgan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br Med J</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="1457" to="1479" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Dixon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Reiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Parikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gandhi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="242" to="248" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Renal sonography in bipolar patients on long-term lithium treatment</title>
		<author>
			<persName><forename type="first">K</forename><surname>Jończyk-Potoczna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Abramowicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chłopocka-Woźniak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Strzelczuk-Judka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Michalak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Czekalski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Rybakowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Ultrasound</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="354" to="359" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Imaging findings of renal toxicity in patients on chronic lithium therapy</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Karaosmanoglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Butros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Arellano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagn Interv Radiol</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="299" to="303" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Use of lithium and anticonvulsants and the rate of chronic kidney disease: a nationwide population-based study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Kessing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Gerds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Feldt-Rasmussen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Andersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Licht</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Psychiatry</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="1182" to="1191" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">One lithium level &gt;1.0 mmol/L causes an acute decline in eGFR: findings from a retrospective analysis of a monitoring database</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kirkham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Skinner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bazire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Twigg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Desborough</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">20</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Renal reactions to changes of lithium dosage</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kusalic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Engelsmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychobiology</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="113" to="116" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">A new equation to estimate glomerular filtration rate</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Levey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName><surname>Iii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">I</forename><surname>Feldman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page" from="604" to="612" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<monogr>
		<title level="m" type="main">International Group for the Study of Lithium (IGSLi), et al. Kidney Int</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Licht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Grabenhenrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Berghöfer</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page">857</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Lithium-induced changes in the body mass index</title>
		<author>
			<persName><forename type="first">B</forename><surname>Mathew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Sundari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Psychiatr Scand</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="538" to="540" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Lithium toxicity profile: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Mcknight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Adida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Budge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Stockton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Goodwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Geddes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">379</biblScope>
			<biblScope unit="issue">9817</biblScope>
			<biblScope unit="page" from="721" to="728" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Lithium usage and renal function testing in a large UK community population; a case-control study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Minay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mcgarvey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Savage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stevenson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fogarty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gen Hosp Psychiatry</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="631" to="635" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Commentary on a recent review of lithium toxicity: what are its implications for clinical practice</title>
		<author>
			<persName><forename type="first">B</forename><surname>Müller-Oerlinghausen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Grof</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Med</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">132</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Lithium nephrotoxicity</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Oliveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Silva</forename><surname>Júnior</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Abreu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Rocha Nde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Franco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Assoc Med Bras</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="600" to="606" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Meta-analysis of effects of lithium usage on serum creatinine levels</title>
		<author>
			<persName><forename type="first">R</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Minay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cardwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fogarty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kelly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1425" to="1431" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Long-term lithium use and risk of renal and upper urinary tract cancers</title>
		<author>
			<persName><forename type="first">A</forename><surname>Pottegård</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hallas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Madsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Friis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="249" to="255" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Effects of lithium on renal function in older adults: systematic review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Rej</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Herrmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shulman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Geriatr Psychiatry Neurol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="51" to="61" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Molecular mechanisms in lithium-associated renal disease: a systematic review</title>
		<author>
			<persName><forename type="first">S</forename><surname>Rej</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Marshe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Do</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Elie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Looper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Urol Nephrol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="1843" to="1853" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Measured and estimated GFR in healthy potential kidney donors</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Rule</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Gussak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Pond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Bergstralh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Stegall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Cosio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Larson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="112" to="119" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Screening for the markers of kidney damage in men and women on long-term lithium treatment</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Rybakowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Abramowicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Drogowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chłopocka-Woźniak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Michalak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Czkalski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Sci Monit</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="R656" to="R660" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Lithium treatment regimen and renal water handling: the significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens</title>
		<author>
			<persName><forename type="first">M</forename><surname>Schou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Amdisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Thomsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vestergaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Hetmar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Mellerup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Plenge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Rafaelsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="387" to="390" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders</title>
		<author>
			<persName><forename type="first">E</forename><surname>Severus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Med</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">34</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Severus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pfennig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ritter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Geddes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Bipolar Disord</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">15</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<monogr>
		<title level="m" type="main">The effect of lithium on glucose-and tolbutamideinduced insulin release and glucose tolerance in the intact rat. Endocrinology</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pishdad</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1980">1980</date>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="1300" to="1304" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Long-term effects of lithium on renal, thyroid, and parathyroid function: a retrospective analysis of laboratory data</title>
		<author>
			<persName><forename type="first">B</forename><surname>Shine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Mcknight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Leaver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Geddes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">386</biblScope>
			<biblScope unit="page" from="461" to="468" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">MRI findings in chronic lithium nephropathy: a case report</title>
		<author>
			<persName><forename type="first">A</forename><surname>Slaughter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jambhekar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Radiol Case Rep</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="15" to="21" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Stevens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="825" to="830" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Lithium increases susceptibility of muscle glucose transport to stimulation by various agents</title>
		<author>
			<persName><forename type="first">I</forename><surname>Tabata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schluter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Gulve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Holloszy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="903" to="907" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Lithium-associated kidney microcysts</title>
		<author>
			<persName><forename type="first">J</forename><surname>Tuazon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Casalino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Syed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Batlle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci World J</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="828" to="829" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Effects of short-and long-term lithium treatment on kidney functioning in patients with bipolar mood disorder</title>
		<author>
			<persName><forename type="first">T</forename><surname>Turan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Eşel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tokgöz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Aslan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sofuoğlu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Utaş</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Keleştimur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog Neuropsychopharmacol Biol Psychiatry</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="561" to="565" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Van den Branden C. Valproic acid attenuates proteinuria and kidney injury</title>
		<author>
			<persName><forename type="first">K</forename><surname>Van Beneden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Geers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pauwels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Mannaerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Verbeelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Van Grunsven</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1863" to="1875" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">The aging kidney: physiological changes</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Weinstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Anderson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Chronic Kidney Dis</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="302" to="307" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Increased risk of solid renal tumors in lithium-treated patients</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zaidan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Stucker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Stengel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Vasiliu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Landais</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="184" to="190" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
